Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Casesophthalmology

Paeds Cases · ophthalmology

Explaining progressive myopia and myopia control to a family — OSCE

Communication and structured-discussion OSCE on progressive myopia in an 8-year-old girl, covering the optical basis of myopia, why cycloplegic refraction confirms the prescription, the stepwise management with spectacles plus myopia control (outdoor time, reduced near work, low-dose atropine 0.05 percent from the LAMP trial, orthokeratology and defocus lenses), the reassurance that under-correction does not slow progression, and the red flags that would prompt urgent referral.

osce communication diagnosis treatment red-flags5 min readVerification in progress

Target exams

MRCPCH ClinicalRACP DCERCPSC Pediatrics
On this page
Study tools

Target exams

MRCPCH ClinicalRACP DCERCPSC Pediatrics
Prompt
An 8-year-old girl is brought in with six months of squinting at the board and worsening distance vision; both parents are myopic, and she spends most of the day on screens with little outdoor time. Her unaided distance acuity is reduced bilaterally and improves to age-normal with a pinhole. The family has read about atropine drops and asks whether she should start them. The candidate must explain the diagnosis, why a cycloplegic test confirms the prescription, the treatment ladder, the role of outdoor time, and the red flags that would bring her back sooner.

Candidate instructions (8-minute station)

You are the paediatric registrar in clinic. An 8-year-old girl has six months of squinting at the board and worsening distance vision. Both her parents wear glasses for short-sightedness, and she spends most of the day on screens with little outdoor time. Her distance vision improves to normal with a pinhole. The family has read about "atropine drops to stop myopia" and asks whether she should start them today. [1]

Your tasks are: [10]

  1. Explain the likely diagnosis — myopia — in plain language, and why both parents being short-sighted and the screen time fit the picture. [1]
  2. Explain why a cycloplegic refraction comes before the final prescription, and what that test involves. [10]
  3. Outline the treatment — spectacles for clear distance vision, plus myopia control built on outdoor time and reduced near work, with low-dose atropine, orthokeratology or defocus lenses as options — and explain why deliberately under-correcting the glasses is not advised. [12]
  4. Address the atropine question honestly — what the LAMP trial showed about 0.05 percent being the most effective of the low doses — and name the red flags that would bring her back sooner. [4]

You are not expected to start atropine in this station — the cycloplegic refraction and the shared decision with the family and ophthalmology come first. [5]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this case. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References5ShowHide
  1. [1]Holden BA; Fricke TR; Wilson DA; Jong M; et al Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology, 2016.PMID 26875007
  2. [4]Yam JC; Jiang Y; Tang SM; Law AKP; et al Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology, 2019.PMID 30514630
  3. [5]Bullimore MA; Ritchey ER; Shah S; Leveziel N; et al The Risks and Benefits of Myopia Control. Ophthalmology, 2021.PMID 33961969
  4. [10]Holmes JM; Clarke MP Amblyopia. Lancet, 2006.PMID 16631913
  5. [12]Németh J, Tapasztó B, Aclimandos WA, et al. Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute. Eur J Ophthalmol, 2021.PMID 33673740
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousExplaining cortical visual impairment and environmental adaptation — OSCEophthalmologyNextExplaining the difference between preseptal and orbital cellulitis — OSCEophthalmology